SPECIFIC INTERFERENCE WITH NUCLEAR ERK1/2 SIGNALING PREVENTS PATHOLOGICAL CARDIAC HYPERTROPHY

被引：0
|
作者：
Ruppert, C. [1 ,2 ]
Deiss, K. [1 ]
Herrmann, S. [2 ,3 ]
Vidal, M. [1 ]
Oezkur, M. [2 ,4 ]
Gorski, A. [2 ,4 ]
Weidemann, F. [2 ,3 ]
Lohse, M. J. [1 ,2 ]
Lorenz, K. [1 ,2 ]
机构：
[1] Univ Wurzburg, Inst Pharmacol & Toxicol, D-97070 Wurzburg, Germany
[2] Univ Hosp Wurzburg, Comprehens Heart Failure Ctr, Wurzburg, Germany
[3] Univ Hosp Wurzburg, Dept Internal Med 1, Wurzburg, Germany
[4] Univ Hosp Wurzburg, Dept Thorac Cardiac & Thorac Vasc Surg, Wurzburg, Germany
来源：
CARDIOLOGY | 2013年 / 126卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：17 / 17
页数：1
相关论文
共 50 条
  • [41] Changes of ERK1/2, PI3K-Akt Signaling Pathway in Pressure Overload-Induced Cardiac Hypertrophy in Mice
    Li Xiao-Mei
    Ma Yi-Tong
    Yang Yi-Ning
    Liu Fen
    Han Wei
    Zhang Jian-Fa
    Chen Bang-Dang
    Gao Xiao-Ming
    CIRCULATION, 2010, 122 (02) : E324 - E324
  • [42] The nuclear translocation of ERK1/2 as an anticancer target
    Alexander Plotnikov
    Karen Flores
    Galia Maik-Rachline
    Eldar Zehorai
    Einat Kapri-Pardes
    Denise A. Berti
    Tamar Hanoch
    Michal J. Besser
    Rony Seger
    Nature Communications, 6
  • [43] Changes of ERK1/2, PI3K-Akt signaling pathway in pressure overload-Induced Cardiac Hypertrophy in Mice
    Li, X. M.
    Ma, Y.
    Yang, Y.
    Liu, F.
    Han, W.
    Chen, B. D.
    Zhang, J. F.
    Gao, X. M.
    CARDIOVASCULAR RESEARCH, 2010, 87 : S122 - S122
  • [44] CYSLTR1 promotes adenoid hypertrophy by activating ERK1/2
    Gao, Wenjie
    Li, Jinying
    Li, Quanheng
    An, Shuhua
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2018, 16 (02) : 966 - 970
  • [45] DUSP8 Regulates Cardiac Ventricular Remodeling by Altering ERK1/2 Signaling
    Liu, Ruijie
    van Berlo, Jop H.
    York, Allen J.
    Vagnozzi, Ronald J.
    Maillet, Marjorie
    Molkentin, Jeffery D.
    CIRCULATION RESEARCH, 2016, 119 (02) : 249 - +
  • [46] Rosuvastatin prevents pressure overload-induced myocardial hypertrophy via inactivation of the Akt, ERK1/2 and GATA4 signaling pathways in rats
    Xu, Xue
    Zhang, Lei
    Liang, Jiangjiu
    MOLECULAR MEDICINE REPORTS, 2013, 8 (02) : 385 - 392
  • [47] Targeting the CaMKII/ERK Interaction in the Heart Prevents Cardiac Hypertrophy
    Cipolletta, Ersilia
    Rusciano, Maria Rosaria
    Maione, Angela Serena
    Santulli, Gaetano
    Sorriento, Daniela
    Del Giudice, Carmine
    Ciccarelli, Michele
    Franco, Antonietta
    Crola, Catherine
    Campiglia, Pietro
    Sala, Marina
    Gomez-Monterrey, Isabel
    De Luca, Nicola
    Trimarco, Bruno
    Iaccarino, Guido
    Illario, Maddalena
    PLOS ONE, 2015, 10 (06):
  • [48] Inhibiting reactive apoptosis by cardiac-specific Nix ablation prevents decompensation of pathological hypertrophy
    Diwan, Abhinav
    Wansapura, Janaka
    Matkovich, Scot
    Syed, Faisal
    Li, Hairong
    Marreez, Yehia
    Dorn, Gerald W.
    CIRCULATION, 2007, 116 (16) : 116 - 116
  • [49] Nuclear ERK1/2 signaling potentiation enhances neuroprotection and cognition via Importinα1/KPNA2
    Indrigo, Marzia
    Morella, Ilaria
    Orellana, Daniel
    d'Isa, Raffaele
    Papale, Alessandro
    Parra, Riccardo
    Gurgone, Antonia
    Lecca, Daniela
    Cavaccini, Anna
    Tigaret, Cezar M.
    Cagnotto, Alfredo
    Jones, Kimberley
    Brooks, Simon
    Ratto, Gian Michele
    Allen, Nicholas D.
    Lelos, Mariah J.
    Middei, Silvia
    Giustetto, Maurizio
    Carta, Anna R.
    Tonini, Raffaella
    Salmona, Mario
    Hall, Jeremy
    Thomas, Kerrie
    Brambilla, Riccardo
    Fasano, Stefania
    EMBO MOLECULAR MEDICINE, 2023, 15 (11)
  • [50] Tetrandrine blocks cardiac hypertrophy by disrupting reactive oxygen species-dependent ERK1/2 signalling
    Shen, Di-Fei
    Tang, Qi-Zhu
    Yan, Ling
    Zhang, Yan
    Zhu, Li-Hua
    Wang, Lang
    Liu, Chen
    Bian, Zhou-Yan
    Li, Hongliang
    BRITISH JOURNAL OF PHARMACOLOGY, 2010, 159 (04) : 970 - 981
12345